Cargando…
Are we aiming to miss in translational autoimmunity treatments?
Autoimmunity treatments, fruitfully pioneered in mouse models, can be disappointing or result in immunosuppression and opportunistic infections in translational trials. Many possible reasons exist, but one major, overlooked reason may be the treatment timing in relation to circadian oscillations of...
Autores principales: | Vaitaitis, Gisela M., Wagner, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259590/ https://www.ncbi.nlm.nih.gov/pubmed/30542620 http://dx.doi.org/10.12688/f1000research.16894.2 |
Ejemplares similares
-
High Distribution of CD40 and TRAF2 in Th40 T Cell Rafts Leads to Preferential Survival of this Auto-Aggressive Population in Autoimmunity
por: Vaitaitis, Gisela M., et al.
Publicado: (2008) -
Galectin-9 Controls CD40 Signaling through a Tim-3 Independent Mechanism and Redirects the Cytokine Profile of Pathogenic T Cells in Autoimmunity
por: Vaitaitis, Gisela M., et al.
Publicado: (2012) -
Th40 cells (CD4(+)CD40(+) Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells
por: Vaitaitis, Gisela M., et al.
Publicado: (2017) -
Modulating CD40 and integrin signaling in the proinflammatory nexus using a 15-amino-acid peptide, KGYY(15)
por: Vaitaitis, Gisela M., et al.
Publicado: (2023) -
Immunotherapy in head and neck cancer: aiming at EXTREME precision
por: Szturz, Petr, et al.
Publicado: (2017)